Diversity as a Strategy for AstraZeneca's Post-COVID-19 Success

Accounts

Contents
Contents...........................................................................................................................................2
INTRODUCTION...........................................................................................................................1
The portfolio's primary purpose.......................................................................................................1
Covid-19 Diversification.............................................................................................................1
Statistical and subjective data are used to assess operations...........................................................2
AstraZeneca's investing selections are based on subjective variables.........................................2
Asset evaluation is influenced by quantitative factors................................................................3
Risk and yield, as well as their possible monetary effect on AstraZeneca......................................4
Yield and volatility......................................................................................................................4
Diversity reduces or minimizes volatility in the dimensions around it.......................................5
Resultant monetary consequences...............................................................................................5
CONCLUSION and RECOMMENDATIONS...............................................................................6
REFERENCES................................................................................................................................7